Thomas Cesnauskas

Senior Quality Control Analyst at Novartis Gene Therapies - Bannockburn, Illinois, United States

Thomas Cesnauskas's Colleagues at Novartis Gene Therapies
Neha Goyani

Quality Assurance Specialist

Contact Neha Goyani

Patrick Millen

Quality Control Investigations Specialist

Contact Patrick Millen

Joshua Wilkins

Manager, TD Process Analytics

Contact Joshua Wilkins

Dawn Fadely

Associate Director, Regional Accounts (access and reimbursement)

Contact Dawn Fadely

View All Thomas Cesnauskas's Colleagues
Thomas Cesnauskas's Contact Details
HQ
+41 79 584 23 26
Location
Chicago,Illinois,United States
Company
Novartis Gene Therapies
Thomas Cesnauskas's Company Details
Novartis Gene Therapies logo, Novartis Gene Therapies contact details

Novartis Gene Therapies

Bannockburn, Illinois, United States • 1100 Employees
Research

Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA).Read Our Community Guidelines: https://bit.ly/39UB7kaHow to reach us:Novartis Gene Therapies2275 Half Day Road, Suite 200Bannockburn, IL 60015Email: avexis.info@novartis.comOffice Phone: 847.572.8280Toll-free Phone: 844.428.3947

Details about Novartis Gene Therapies
Frequently Asked Questions about Thomas Cesnauskas
Thomas Cesnauskas currently works for Novartis Gene Therapies.
Thomas Cesnauskas's role at Novartis Gene Therapies is Senior Quality Control Analyst.
Thomas Cesnauskas's email address is ***@. To view Thomas Cesnauskas's full email address, please signup to ConnectPlex.
Thomas Cesnauskas works in the Research industry.
Thomas Cesnauskas's colleagues at Novartis Gene Therapies are Nedra Stuart, Tyler Muntean, Dan Overton, Neha Goyani, Patrick Millen, Joshua Wilkins, Dawn Fadely and others.
Thomas Cesnauskas's phone number is +41 79 584 23 26
See more information about Thomas Cesnauskas